Trafalgar International (GCAN) FCF Margin (2017 - 2021)
Trafalgar International (GCAN) posted FCF Margin of 299.22% for Q2 2021, down 80.16% on a QoQ basis from 166.09% in Q2 2020, and down 13313.0% year-over-year from N/an in Q2 2020.
Analysis
Trafalgar International (GCAN) FCF Margin (2017 - 2021) Analysis & Trends
Trafalgar International has reported FCF Margin for 5 years, with the latest figure at 299.22% in Q2 2021.
- On a quarterly basis, FCF Margin fell 13313.0% year-over-year to 299.22% in Q2 2021; TTM through Dec 2021 was 1864.08%, a 131287.0% decrease from a year earlier, with the FY2021 full-year figure at 1864.08%, down 126124.0% from the prior year.
- FCF Margin was 299.22% for Q2 2021 at Trafalgar International, down from 166.09% in the prior quarter.
- The five-year high for FCF Margin was 107.62% in Q1 2018, with the low at 19098.63% in Q2 2017.
- Average FCF Margin over 5 years is 3774.03%, with a median of 385.01% recorded in 2021.
- The sharpest annual moves came in 2018 and 2021: FCF Margin jumped 1919797 bps in 2018, then tumbled 13313 bps in 2021.
- Over 5 years, FCF Margin stood at 9021.32% in 2017, then jumped by 101 bps to 99.34% in 2018, then sank by 574 bps to 470.8% in 2019, then surged by 65 bps to 166.09% in 2020, then slumped by 80 bps to 299.22% in 2021.
- The last three FCF Margin figures came in at 299.22% (Q2 2021), 166.09% (Q2 2020), and 470.8% (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.54 Bn | 621.78 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 446.88 Bn | 440.31 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 357.51 Bn | 350.37 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 267.62 Bn | 259.93 Bn | 11.24 Bn | 43.05% |
| 5 | Pfizer | 156.52 Bn | 144.82 Bn | 10.94 Bn | 2.01% |
| 6 | Sanofi | 52.22 Bn | 44.84 Bn | 10.79 Bn | 25.52% |
| 7 | Revolution Medicines | 42.89 Bn | 42.89 Bn | - | - |
| 8 | Incyte | 24.62 Bn | 20.09 Bn | 1.57 Bn | 29.58% |
| 9 | United Therapeutics | 21.47 Bn | 18.81 Bn | 683.80 Mn | 26.25% |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -299.22% |
| Jun 30, 2020 | -166.09% |
| Dec 31, 2019 | -470.80% |
| Sep 30, 2019 | -1,343.09% |
| Jun 30, 2018 | 99.34% |
| Mar 31, 2018 | 107.62% |
| Sep 30, 2017 | -9,021.32% |
| Jun 30, 2017 | -19,098.63% |